Roland R. Griffiths

Also affiliated with Johns Hopkins Medicine, Behavioral Pharma (United States)

NeurosciencePsychologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 11 papers. Top paper: “Alprazolam absorption kinetics affects abuse liability*”.

Alprazolam absorption kinetics affects abuse liability*

Clinical Pharmacology & Therapeutics(1995)10.1016/0009-9236(95)90162-0

N/A

0.624DataRank · unranked

63 citations

Suzette M. Evans, Joseph C. Fleishaker, Roland R. Griffiths, Geoffrey K. Mumford

Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer

Nature Mental Health(2024)10.1038/s44220-024-00331-0

N/A

0.360DataRank · unranked

10 citations

Jack Grinband, Gabrielle Agin-Liebes, Connor J. Kinslow, Richard J. Zeifman, Michael P. Bogenschutz +3 more

Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

Psychopharmacology(2020)10.1007/s00213-020-05533-9

N/A

0DataRank · unranked

51 citations

Matthew W. Johnson, Roland R. Griffiths, Theresa M. Carbonaro

Recent Progress in Lyme Disease and Remaining Challenges

Frontiers in Medicine(2021)10.3389/fmed.2021.666554

N/A

0DataRank · unranked

155 citations

Brandon L. Jutras, Elizabeth J. Horn, Monica E. Embers, Allison Bailey, Robert L. Moritz +26 more

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities

The International Journal of Neuropsychopharmacology(2021)10.1093/ijnp/pyab026

N/A

0DataRank · unranked

56 citations

Matthew W. Johnson, Roland R. Griffiths, Manoj K. Doss, Albert Garcia‐Romeu, Sandeep M. Nayak +4 more

Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic

Drug and Alcohol Dependence(2020)10.1016/j.drugalcdep.2020.107849

N/A

0DataRank · unranked

179 citations

David J. Cox, Kirsten E. Smith, Kelly E. Dunn, Roland R. Griffiths, Albert Garcia‐Romeu

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

Frontiers in Neuroergonomics(2022)10.3389/fnrgo.2021.784576

N/A

0DataRank · unranked

17 citations

Yun Zhou, Theresa M. Carbonaro, Joshua Roberts, Gwenn S. Smith, Roland R. Griffiths +2 more

Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion

Psychedelic Medicine(2022)10.1089/psymed.2022.0003

N/A

0DataRank · unranked

7 citations

Charles D. Nichols, Kathryn A. Cunningham, Mark A. Geyer, Roland R. Griffiths, David E. Nichols +1 more

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis

Psychiatry Research(2023)10.1016/j.psychres.2023.115349

N/A

0DataRank · unranked

24 citations

Per Carlbring, Robin Carhart‐Harris, Alan K. Davis, David Nutt, Roland R. Griffiths +3 more

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder

JAMA Psychiatry(2022)10.1001/jamapsychiatry.2022.4020

N/A

0DataRank · unranked

22 citations

Bethea A. Kleykamp, Sandra D. Comer, Roland R. Griffiths, Andrew S. Huhn, Matthew W. Johnson +22 more

Emotions and brain function are altered up to one month after a single high dose of psilocybin

Scientific Reports(2020)10.1038/s41598-020-59282-y

N/A

0DataRank · unranked

376 citations

Manoj K. Doss, Nathan D. Sepeda, James J. Pekar, Roland R. Griffiths, Frederick S. Barrett